Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 55209
MIM: 615743
HGNC: 25566
Ensembl: ENSG00000168137
Variants:
dbSNP: 55209
ClinVar: 55209
TCGA: ENSG00000168137
COSMIC: SETD5
RNA/Proteins
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 36875494 | 2023 | Structure, activity and function of the lysine methyltransferase SETD5. | 2 |
| 37264456 | 2023 | SETD5 haploinsufficiency affects mitochondrial compartment in neural cells. | 2 |
| 36875494 | 2023 | Structure, activity and function of the lysine methyltransferase SETD5. | 2 |
| 37264456 | 2023 | SETD5 haploinsufficiency affects mitochondrial compartment in neural cells. | 2 |
| 35063407 | 2022 | SETD5 Regulates Glycolysis in Breast Cancer Stem-Like Cells and Fuels Tumor Growth. | 8 |
| 35063407 | 2022 | SETD5 Regulates Glycolysis in Breast Cancer Stem-Like Cells and Fuels Tumor Growth. | 8 |
| 33129761 | 2021 | Su(var)3-9, Enhancer of Zeste, and Trithorax Domain-Containing 5 Facilitates Tumor Growth and Pulmonary Metastasis through Up-Regulation of AKT1 Signaling in Breast Cancer. | 6 |
| 33822517 | 2021 | SET Domain-Containing Protein 5 Enhances the Cell Stemness of Non-Small Cell Lung Cancer via the PI3K/Akt/mTOR Pathway. | 7 |
| 33129761 | 2021 | Su(var)3-9, Enhancer of Zeste, and Trithorax Domain-Containing 5 Facilitates Tumor Growth and Pulmonary Metastasis through Up-Regulation of AKT1 Signaling in Breast Cancer. | 6 |
| 33822517 | 2021 | SET Domain-Containing Protein 5 Enhances the Cell Stemness of Non-Small Cell Lung Cancer via the PI3K/Akt/mTOR Pathway. | 7 |
| 31474762 | 2020 | The pleiotropy associated with de novo variants in CHD4, CNOT3, and SETD5 extends to moyamoya angiopathy. | 25 |
| 31981592 | 2020 | SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness. | 8 |
| 31474762 | 2020 | The pleiotropy associated with de novo variants in CHD4, CNOT3, and SETD5 extends to moyamoya angiopathy. | 25 |
| 31981592 | 2020 | SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness. | 8 |
| 30190612 | 2019 | Rare variants in the genetic background modulate cognitive and developmental phenotypes in individuals carrying disease-associated variants. | 90 |
Citation
Dessen P
SETD5 (SET domain containing 5)
Atlas Genet Cytogenet Oncol Haematol. 2014-11-01
Online version: http://atlasgeneticsoncology.org/gene/73156/setd5-(set-domain-containing-5)
